Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary efficacy of the combination of INCB024360 and MEDI4736 in subjects with selected advanced solid tumors.
    Difference
    0.2%
    Check dated 2024-06-06T14:37:35.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, detailed eligibility criteria for inclusion and exclusion have been specified.
    Difference
    21%
    Check dated 2024-05-22T21:26:53.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:29:09.000Z thumbnail image

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.